Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2006 1
2007 4
2008 3
2009 2
2010 1
2012 2
2013 3
2014 1
2015 1
2019 3
2020 1
2021 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
The Siderophore Transporter Sit1 Determines Susceptibility to the Antifungal VL-2397.
Dietl AM, Misslinger M, Aguiar MM, Ivashov V, Teis D, Pfister J, Decristoforo C, Hermann M, Sullivan SM, Smith LR, Haas H. Dietl AM, et al. Among authors: smith lr. Antimicrob Agents Chemother. 2019 Sep 23;63(10):e00807-19. doi: 10.1128/AAC.00807-19. Print 2019 Oct. Antimicrob Agents Chemother. 2019. PMID: 31405865 Free PMC article.
Pharmacokinetics and Immunogenicity of ASP0113 in CMV-Seronegative Dialysis Patients and CMV-Seronegative and -Seropositive Healthy Subjects.
Bonate PL, Van Sant C, Cho K, Zook EC, Smith LR, Boutsaboualoy S, Ye M, Wang X, Wu R, Koester A, Rammelsberg D, Goldwater R, Marbury TC. Bonate PL, et al. Among authors: smith lr. Clin Pharmacol Drug Dev. 2020 May;9(4):444-455. doi: 10.1002/cpdd.792. Epub 2020 Mar 23. Clin Pharmacol Drug Dev. 2020. PMID: 32202705 Clinical Trial.
Reanalysis of TransVax immunogenicity.
Kharfan-Dabaja MA, Boeckh M, Wilck MB, Langston AA, Chu AH, Wloch MK, Smith LR, Rolland AP, Kenney RT. Kharfan-Dabaja MA, et al. Among authors: smith lr. Lancet Infect Dis. 2013 Jan;13(1):18. doi: 10.1016/S1473-3099(12)70296-7. Lancet Infect Dis. 2013. PMID: 23257230 No abstract available.
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients.
Ljungman P, Bermudez A, Logan AC, Kharfan-Dabaja MA, Chevallier P, Martino R, Wulf G, Selleslag D, Kakihana K, Langston A, Lee DG, Solano C, Okamoto S, Smith LR, Boeckh M, Wingard JR, Cywin B, Fredericks C, Lademacher C, Wang X, Young J, Maertens J. Ljungman P, et al. Among authors: smith lr. EClinicalMedicine. 2021 Mar 19;33:100787. doi: 10.1016/j.eclinm.2021.100787. eCollection 2021 Mar. EClinicalMedicine. 2021. PMID: 33842870 Free PMC article.
Modifying the HIV-1 env gp160 gene to improve pDNA vaccine-elicited cell-mediated immune responses.
Megati S, Garcia-Hand D, Cappello S, Roopchand V, Masood A, Xu R, Luckay A, Chong SY, Rosati M, Sackitey S, Weiner DB, Felber BK, Pavlakis GN, Israel ZR, Smith LR, Eldridge JH, Sidhu MK, Egan MA. Megati S, et al. Among authors: smith lr. Vaccine. 2008 Sep 19;26(40):5083-94. doi: 10.1016/j.vaccine.2008.03.092. Epub 2008 Apr 24. Vaccine. 2008. PMID: 18485543 Free PMC article.
24 results